Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome analysis of BMDCs treated with nanovesicle vaccines

ABSTRACT: We carried out in vitro transcriptome analysis of BMDCs treated with PEG-IM-MP and PEG-MP nanovesicles to understand the regulatory pathway of the immune response concerning gene expression.

ORGANISM(S): Mus musculus

PROVIDER: GSE179021 | GEO | 2021/06/29

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Transcriptome analysis of BMDCs treated with nanovesicle vaccines

Project description:Transcriptome analysis of BMDCs treated with nanovesicle vaccines

| PRJNA741932 | ENA

small RNAseq in donor BMDCs and BMDCs that received exosomes

Project description:small RNAseq was preformed on Wt bone marrow-derived dendritic cells (BMDC) and miR-155 and miR-146a double knockout (DKO) BMDCs that received Wt exosomes to investigate the differences in transferred miRNA Small RNA profiles were generated from Wt donor BMDCs and DKO BMDCs given Wt exosomes 3 replicates in each group

2016-07-03 | E-GEOD-67946 | biostudies-arrayexpress

Gene expression profiles of mice BMDCs treated with Nitidine Chloride or vehicle following LPS stimulation

Project description:Nitidine Chloride(NC) were found to enhance IL-10 production in LPS-stimulated Bone-marrow dendritic cells(BMDCs ) ,while at the same time inhibit pro-inflammatory cytokines production, such as TNF- α and IL-6. BMDCs were treated with NC or vehicle following LPS stimulation to find out the influence of NC on BMDCs that regulate cytokines expression. This study indicated that NC regulate numerous gene expression, thus influence IL-10 and pro-inflammatory cytokines production in LPS-treated BMDCs.

2017-08-05 | GSE102135 | GEO

Comparison between CD103+ cDC1s from IL-33-treated Flt3L-BMDCs and GM-CSF-treated Flt3L-BMDCs

Project description:To assess genotypic differences between IL-33-induced CD103+ cDC1s and GM-CSF-induced CD103+ cDC1s IL-33 or GM-CSF was treated at 5 ng/ml on the day 5 of Flt3L-BMDC generation and then the cells were incubated for an additional 5 days Then, we performed RNA sequencing of CD103+ cDC1s isolated from IL-33 or GM-CSF-treated Flt3L-BMDCs

2023-05-30 | GSE226585 | GEO

Next Generation Sequencing Facilitates Quantitative Analysis of Transcriptomes of BMDCs treated without or with exosomes from tumor cells or normal cells

Project description:The goals of this study are to compare the transcriptome profiling (RNA-seq) of tumor cell-derived exosome treated BMDCs to normal cell-derived exosome treaed BMDCs or untreated BMDCs to explore the differential regulated signaling pathways or cellular processes.

2021-01-04 | GSE155881 | GEO

small RNAseq in donor BMDCs and BMDCs that received exosomes

2016-01-01 | GSE67946 | GEO

RNA-seq of mouse BMDCs treated with compound #634 or vehicle controls

Project description:We performed RNA-seq analysis to explore the effects of compound #634 (ethyl 2-(benzo[c][1,2,5]thiadiazole-4-sulfonamido)-4,5-dimethylthiophene-3-carboxylate) on RNA transcription of bone marrow-derived dendritic cells (BMDCs).

2023-11-01 | E-MTAB-12377 | biostudies-arrayexpress

Ad-MyD88 infected bmDCs: Control vs. Ad-MyD88 infected

Project description:Transcriptional profiling of Bone-Marrow derived mouse Dendritic Cells (bmDCs) infected with Ad-MyD88 vs. Ad-GFP or mock infected

2010-01-29 | GSE19006 | GEO

Expression data from BMDCs treated with BI2536 or vehicle control and stimulated with LPS or poly(I:C)

Project description:We used microarrays to detail the global programme of gene expression underlying Polo-like kinase inhibition with BI 2536 compound in mouse bone marrow-derived dendritic cells (BMDCs) stimulated with Toll-like receptor agonists LPS and poly(I:C). CD11c+ BMDCs were treated for 1 hour with BI 2536 (1µM) or vehicle control (DMSO) prior to stimulation with LPS or poly(I:C) for 4 h. Total RNA was extracted and prepared for hybridization on Affymetrix microarrays.

2011-04-12 | E-GEOD-28520 | biostudies-arrayexpress

Expression data from BMDCs treated with BI2536 or vehicle control and stimulated with LPS or poly(I:C)

2011-04-12 | GSE28520 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data